Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

TAKURO OKADA; TAKASHI MATSUKI; CHIHIRO FUSHIMI; ISAKU OKAMOTO; HIROKI SATO; TAKAHITO KONDO; KUNIHIKO TOKASHIKI; TATSUYA ITO; TATSUO MASUBUCHI; YUICHIRO TADA; KOUKI MIURA; KENJI HANYU; GO OMURA; HIDEKI TAKAHASHI; TAKU YAMASHITA; NOBUHIKO ORIDATE; KIYOAKI TSUKAHARA

doi:10.21873/anticanres.15996

Research ArticleClinical Studies

Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

TAKURO OKADA, TAKASHI MATSUKI, CHIHIRO FUSHIMI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TATSUYA ITO, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, KENJI HANYU, GO OMURA, HIDEKI TAKAHASHI, TAKU YAMASHITA, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA

Anticancer Research October 2022, 42 (10) 4907-4912; DOI: https://doi.org/10.21873/anticanres.15996

TAKURO OKADA

1Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: taku-hns{at}tokyo-med.ac.jp

TAKASHI MATSUKI

2Department of Otorhinolaryngology, Head and Neck Surgery, Kitasato University School of Medicine, Sagamihara, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

CHIHIRO FUSHIMI

3Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

ISAKU OKAMOTO

1Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROKI SATO

1Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAKAHITO KONDO

4Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KUNIHIKO TOKASHIKI

1Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TATSUYA ITO

1Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TATSUO MASUBUCHI

3Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUICHIRO TADA

3Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KOUKI MIURA

3Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KENJI HANYU

3Department of Head and Neck Oncology and Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

GO OMURA

5Department of Head and Neck Oncology, National Cancer Center Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIDEKI TAKAHASHI

6Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University, Yokohama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAKU YAMASHITA

2Department of Otorhinolaryngology, Head and Neck Surgery, Kitasato University School of Medicine, Sagamihara, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

NOBUHIKO ORIDATE

6Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University, Yokohama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KIYOAKI TSUKAHARA

1Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Kaplan-Meier survival curves of progression-free survival (a) and overall survival (b) in patients with platinum-refractory and platinum-sensitive recurrent/metastatic head and neck squamous cell carcinoma receiving nivolumab.

Tables

Figures

PreviousNext

In this issue

Anticancer Research

Vol. 42, Issue 10

October 2022

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 10 + 10 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Anticancer Research Oct 2022, 42 (10) 4907-4912; DOI: 10.21873/anticanres.15996

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Anticancer Research Oct 2022, 42 (10) 4907-4912; DOI: 10.21873/anticanres.15996

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Efficacy of Nivolumab and Pembrolizumab in Platinum-sensitive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Google Scholar

Keywords

nivolumab
squamous cell carcinoma
head and neck
platinum-refractory
platinum-sensitive

Main menu

User menu

Search

Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords